Real Chemistry, a 2022 MM+M Agency 100 honoree, generated $555 million in revenue in 2022, reflecting 17% year-over-year growth, according to a company release Wednesday morning.

Real Chemistry reported double-digit growth in its advertising and communications segments during 2022 as well as up to 50% growth in categories like data, AI products and services, market access, medical affairs, influencer and celebrity.

According to the 2022 MM+M Agency 100 revenue table, Real Chemistry finished 2021 with $439 million.

The firm highlighted a number of developments that boosted its performance in 2022, including the launch of its 21Grams gaming discipline as well as its acquisition of conversationHEALTH to help healthcare and life sciences companies create personalized virtual experiences for patients. 

The company added that this marks the 21st consecutive year of double-digit top-line growth. 

“Real Chemistry’s financial performance reflects our success doing impactful work at scale, and I can’t thank our team and clients enough,” Real Chemistry CEO Shankar Narayanan said in a statement. “Crossing the half-billion dollar threshold is a significant milestone for our company. But it’s more than revenue growth that drives us. It’s the spirit of unparalleled innovation which gives us insights and integrated capabilities across the entire spectrum of services needed by our clients. With the power to continue to innovate at scale and serve as the leading partner of choice for our clients, we are well positioned to drive our next decade of growth.”

Narayanan added that the company remains committed to the potential of data and AI-drive products, investing in innovative and specialized solutions that can assist clients.

The significant growth comes as no surprise to industry observers as Narayanan said in September that the company was on track for 20% organic revenue growth for the year. 

Real Chemistry announced its financial performance one week after buying the doctor-focused ad-tech firm TI Health. While terms were not disclosed, Real Chemistry said there are no layoffs planned, that TI Health will be integrated into Swoop and go to market under the Swoop brand. This continues the company’s buying spree, which totals four data-focused agencies in the past three years.